Korea Quality Re-Rating Watch 11-12: Dongkook, TYM, Celltrion

KOSPI is up 5.6% in five sessions, but 1,591 stocks fell on Nov 12. Dongkook Pharmaceutical, TYM and Celltrion lead today's quality re-rating screen.

— Recommendations 0

Macro Dashboard

IndicatorLevelChange
KOSPI5,342.73+5.59% (5-day window)
KOSDAQ696.53+8.11% (5-day window)
USD/KRW1,331.9-1.80%
VIX18.32-28.55%
Brent$92.05-0.56%
US 10Y5.00%+0.16pp

Regime verdict: Korea is withheld (UNKNOWN). The raw model signal is Bear, but one derivatives input (open interest) is two sessions old, so the label was not committed. The US is Neutral. It was downgraded from Bull because the 10-year yield rose more than 0.15pp.

The index changes above are five-day windows built from Yahoo data. The source does not give a one-day change. The FinanceDataReader daily close was lower: 5,305.47 for KOSPI and 688.45 for KOSDAQ. Both indices sit well below their 200-day averages (KOSPI 6,520, KOSDAQ 961).

Market Wrap

The KOSPI and Korea stock market bounce is real at the index level. The average stock told a different story today.

Of 2,595 stocks, 743 rose, 1,591 fell and 261 were flat. The advance/decline proxy was 46.7 and the average stock fell 0.76%. Only 20.1% of the 2,692 stocks in the screening universe trade above their 50-day average. That figure is 15.2% against the 200-day average. This was a selective, narrow session, not a broad rally.

Weak spots: Several mid-caps fell sharply and appeared on the foreign selling list. DB HiTek (000990.KS) fell 16.36%, Dalba Global (483650.KS) fell 13.97%, and SPG (058610.KS) fell 16.09%. On the institutional selling list, NC (036570.KS) fell 9.19%, NAVER (035420.KS) fell 6.43% and Meritz Financial Holdings (138040.KS) fell 13.05%. Hyundai Motor (005380.KS) fell 2.20%.

Flow signals: Foreigners ranked financials high among net buyers: KB Financial (105560.KS), Shinhan Financial (055550.KS) and Hana Financial (086790.KS), even though KB and Shinhan slipped. Institutions were net sellers of the same three names. Institutions bought smaller, higher-volatility names such as Estec (069510.KS, +19.83%), HYBE (352820.KS, +5.35%) and Samyang Foods (003230.KS, +4.46%). The source gives rankings only. Net buying amounts and turnover were not available.

Derivatives and passive flow: Program trading was a net buy of about 338.9 billion won. Basis was -6.07, and net ETF creation was about 1.55 trillion won. Open interest was 83,678, but that reading dates from Nov 10.

The macro backdrop is mixed. The won strengthened and VIX fell. The US 10-year yield rose to 5.00%, and the dollar index rose to 102.9.

Today’s Quality Re-Rating Candidates

The screen asks for three layers. The first is quality: a business with solid returns and growing profit. The second is money flow: foreign and quality-institution buying that absorbs individual selling. The third is a re-rating or earnings catalyst: margin expansion, estimate upgrades, or post-earnings drift (PEAD).

The strict overlap check found no stock in two or more of the screeners it reads. That check read only the PEAD screener today. The KR Meta Screener, which combines several screener families, supplies the ranking below. Its weights favor consensus-upgrade signals (weight 2.18) over the four financial-factor screens (0.54), which have lagged their candidate pool recently.

RankTickerNameFamiliesKey metrics
1086450.KSDongkook Pharmaceutical4ROE 9.9%, OP +20.1% YoY, margin +0.5pp, RS 90
2002900.KSTYM2Consensus z +0.74, OP +298% YoY, buyback decision Nov 11
3068270.KSCelltrion3OP +137.5% YoY, margin +14.2pp, 4 catalyst filings
4121600.KQNano Advanced Materials25-day foreign + quality-institution buying +17.2bn won, margin +0.8pp
5002790.KSAmorepacific Holdings2Quiet accumulation, pivot gap +5.0%, RS80 pass
6089590.KSJeju Air1Consensus z +5.10, individual selling absorbed (14.2bn won)
7272450.KSJin Air1Consensus z +0.67, two IR filings
8020150.KSLotte Energy Materials1Consensus z +1.42, 5 catalyst filings

Dongkook Pharmaceutical (086450.KS) is a Korean drugmaker. It leads because four screener families flag it: Quality Compounder, Cycle Rerating, PEAD and Quiet Accumulation. Foreign and quality-institution buyers absorbed about 4.9 billion won of individual selling. The only recent DART filing is a shareholder meeting notice, so no company-specific catalyst is visible. The financials come from the 2025 annual filing, which is 245 days old. The next check is the latest quarterly report, to confirm the margin trend still holds.

TYM (002900.KS) makes agricultural machinery. Its case rests on estimate upgrades and official events. The company filed a treasury share buyback decision on Nov 11 and preliminary earnings on Nov 4. The PEAD screen shows operating profit up about 298% year on year, but that figure comes from a snapshot source with no filing date. It is a growth filter, not a consensus surprise. Check the earnings release and the buyback size.

Celltrion (068270.KS) is a biosimilar maker. It is flagged for margin expansion (+14.2pp), PEAD and RS80 leadership, and about 100 billion won of individual selling was absorbed by foreign and quality-institution buyers. DART shows a catalyst filing on Nov 2: a European Phase 3 trial plan for its CTP13 subcutaneous product in rheumatoid arthritis. The financial data is also from the 2025 annual filing. The next check is the Q3 numbers and the trial timeline.

Nano Advanced Materials (121600.KQ) has the strongest money-flow evidence outside the top three. It also filed a share cancellation decision today. Korean Air (003490.KS) and Samah Aluminum (006110.KS) appear in the full ranking, with consensus upgrades as their only screen signal.

All names are screened candidates for further research, not recommendations. KT Genie Music (043610.KS) carries one DART risk-type filing and is excluded from the top table.

Sources: KR Meta Screener, KR PEAD screener, macro regime model and Research OS snapshot, all dated 2026-11-12. Yahoo index levels are intraday-capable regular market prices.

Built with Hugo
Theme Stack designed by Jimmy